1. Home
  2. FTRE vs FPF Comparison

FTRE vs FPF Comparison

Compare FTRE & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$19.79

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$16.80

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTRE
FPF
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
FTRE
FPF
Price
$19.79
$16.80
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$14.06
N/A
AVG Volume (30 Days)
970.2K
105.5K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
8.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,723,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.00
N/A
52 Week Low
$8.31
$17.01
52 Week High
$21.39
$19.75

Technical Indicators

Market Signals
Indicator
FTRE
FPF
Relative Strength Index (RSI) 45.16 18.65
Support Level $17.37 N/A
Resistance Level $18.13 $18.18
Average True Range (ATR) 0.77 0.19
MACD -0.13 -0.08
Stochastic Oscillator 40.95 8.33

Price Performance

Historical Comparison
FTRE
FPF

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: